Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland

Potential Coverage of the 4CMenB Vaccine against Invasive Serogroup B <italic toggle="yes">Neisseria meningitidis</italic> Isolated from 2009 to 2013 in the Republic of Ireland

ABSTRACT Neisseria meningitidis is a common cause of bacterial meningitis in children and young adults worldwide. The 4CMenB vaccine (Bexsero), developed to combat meningococcal serogroup B (MenB) disease, contains subcapsular antigens that may induce immunity against strains of N. meningitidis, reg...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Robert M. Mulhall, Desiree Bennett, Robert Cunney, Ray Borrow, Jay Lucidarme, Jamie Findlow, Keith A. Jolley, James Bray, Martin C. J. Maiden, Monica Moschioni, Laura Serino, Maria Stella, Duccio Medini
Formato: article
Lenguaje:EN
Publicado: American Society for Microbiology 2018
Materias:
4CMenB
MATS
MenB
NHBA
NadA
Neisseria meningitidis
Microbiology
QR1-502
Acceso en línea:https://doaj.org/article/ef4e9edffb8840829452eca8bd097553
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares